P2Et-driven activation of PERK in melanoma cells promotes ER-calcium release, disrupts mitochondrial membrane potential, and triggers upregulation of ICD drivers as surface calreticulin expression, and extracellular release of ATP and HMGB1 [18,19,15]. Here, EIF2AK3 is linked to melanoma.